D5BH:F:F-Xtrackers - MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 70.08

Change

-0.04 (-0.06)%

Market Cap

USD 0.36B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.10 (+0.39%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 117.80B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.14 (+0.26%)

USD 92.18B
SXR8:F iShares Core S&P 500 UCITS ETF..

+2.58 (+0.49%)

USD 85.13B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.07 (+0.30%)

USD 75.40B
EUNL:F iShares Core MSCI World UCITS ..

-0.08 (-0.08%)

USD 72.04B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 56.70B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 55.70B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.58 (+0.60%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.75 (+0.79%)

USD 51.63B

ETFs Containing D5BH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.68% 48% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.68% 46% F 51% F
Trailing 12 Months  
Capital Gain 9.43% 56% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.43% 54% F 55% F
Trailing 5 Years  
Capital Gain 47.91% 73% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.91% 72% C 58% F
Average Annual (5 Year Horizon)  
Capital Gain 9.93% 82% B 76% C+
Dividend Return 9.93% 80% B- 69% C-
Total Return N/A 16% F 33% F
Risk Return Profile  
Volatility (Standard Deviation) 17.88% 27% F 63% D
Risk Adjusted Return 55.52% 81% B- 85% B
Market Capitalization 0.36B 54% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.